# Purinergic Signaling and the Postmenopausal Heart

> **NCT06015776** · — · RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Diastolic Heart Failure
- Heart Failure With Preserved Ejection Fraction

## Interventions

- **OTHER:** Gender

## Key facts

- **NCT ID:** NCT06015776
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2030-06
- **Final completion:** 2030-06
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06015776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06015776, "Purinergic Signaling and the Postmenopausal Heart". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06015776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*